|
Volumn 55, Issue 3, 2001, Pages 171-175
|
Setting threshold limits for the significance of objectionable microorganisms in oral pharmaceutical products
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BACTERIUM CONTAMINATION;
BACTERIUM ISOLATION;
DRUG MANUFACTURE;
IMMUNE DEFICIENCY;
MAXIMUM ALLOWABLE CONCENTRATION;
MICROORGANISM;
OPPORTUNISTIC INFECTION;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
ADMINISTRATION, ORAL;
BACTERIA;
DECISION TREES;
DRUG CONTAMINATION;
HUMANS;
QUALITY ASSURANCE, HEALTH CARE;
|
EID: 0034982979
PISSN: 10797440
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (17)
|